Literature DB >> 11550941

Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and of classical group sequential approaches.

H H Müller1, H Schäfer.   

Abstract

A general method is presented integrating the concept of adaptive interim analyses into classical group sequential testing. This allows the researcher to represent every group sequential plan as an adaptive trial design and to make design changes during the course of the trial after every interim analysis in the same way as with adaptive designs. The concept of adaptive trial designing is thereby generalized to a large variety of possible sequential plans.

Mesh:

Year:  2001        PMID: 11550941     DOI: 10.1111/j.0006-341x.2001.00886.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  37 in total

Review 1.  Modelling and simulation in the development and use of anti-cancer agents: an underused tool?

Authors:  Ferdinand Rombout; Leon Aarons; Mats Karlsson; Anthony Man; France Mentré; Peter Nygren; Amy Racine; Hans Schaefer; Jean-Louis Steimer; Iñaki Troconiz; Achiel van Peer
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-12       Impact factor: 2.745

2.  Flexible design for following up positive findings.

Authors:  Kai Yu; Nilanjan Chatterjee; William Wheeler; Qizhai Li; Sophia Wang; Nathaniel Rothman; Sholom Wacholder
Journal:  Am J Hum Genet       Date:  2007-08-03       Impact factor: 11.025

3.  A pragmatic, adaptive clinical trial design for a rare disease: The FOcal Cerebral Arteriopathy Steroid (FOCAS) trial.

Authors:  Yeonhee Park; Heather J Fullerton; Jordan J Elm
Journal:  Contemp Clin Trials       Date:  2019-10-13       Impact factor: 2.226

4.  A Bayesian adaptive design for two-stage clinical trials with survival data.

Authors:  Uttam Bandyopadhyay; Atanu Biswas; Rahul Bhattacharya
Journal:  Lifetime Data Anal       Date:  2009-11-04       Impact factor: 1.588

5.  Adaptive enrichment designs for clinical trials.

Authors:  Noah Simon; Richard Simon
Journal:  Biostatistics       Date:  2013-03-21       Impact factor: 5.899

6.  A Bayesian adaptive design with biomarkers for targeted therapies.

Authors:  Jens C Eickhoff; KyungMann Kim; Jason Beach; Jill M Kolesar; Jason R Gee
Journal:  Clin Trials       Date:  2010-06-22       Impact factor: 2.486

7.  Choosing inclusion criteria that minimize the time and cost of clinical trials.

Authors:  Charles F Babbs
Journal:  World J Methodol       Date:  2014-06-26

8.  Methodology guideline for clinical studies investigating traditional Chinese medicine and integrative medicine: executive summary.

Authors:  Jian-Ping Liu; Ke-Ji Chen
Journal:  Complement Ther Med       Date:  2015-10       Impact factor: 2.446

9.  Design and Organization of the Dexamethasone, Light Anesthesia and Tight Glucose Control (DeLiT) Trial: a factorial trial evaluating the effects of corticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery.

Authors:  Basem Abdelmalak; Ankit Maheshwari; Edward Mascha; Sunita Srivastava; Theodore Marks; Wh Wilson Tang; Andrea Kurz; Daniel I Sessler
Journal:  BMC Anesthesiol       Date:  2010-06-30       Impact factor: 2.217

10.  Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933].

Authors:  Francisco Martinez-Torres; Sanjay Menon; Maria Pritsch; Norbert Victor; Ekkehart Jenetzky; Katrin Jensen; Eva Schielke; Erich Schmutzhard; Jan de Gans; Chin-Hee Chung; Steffen Luntz; Werner Hacke; Uta Meyding-Lamadé
Journal:  BMC Neurol       Date:  2008-10-29       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.